Netherlands· NL-9e42ca391718
Nuvaxovid XBB.1.5 dispersie voor injectie
A covid-19, protein-untereinheit product containing recombinant spike proteïne zonder signaal peptide van het sars-cov-2 virus, registered in Netherlands by Sanofi Winthrop Industrie. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Covid-19, protein-untereinheit is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BN04 (covid-19, protein-untereinheit), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Covid-19, protein-untereinheit · ATC J07BN04
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RECOMBINANT SPIKE PROTEÏNE ZONDER SIGNAAL PEPTIDE VAN HET SARS-COV-2 VIRUS
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Netherlands (NL)
- ATC code
- J07BN04
- ATC class
- Covid-19, Protein-Untereinheit
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/21/1618
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BN04
Covid-19, protein-untereinheit, as other registers publish it.
- BelgiumBimervaxHipra Human Health
- PolandBimervaxHipra Human Health, S.L.U.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- IcelandBIMERVAXHipra Human Health S.L.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- FinlandBIMERVAXHipra Human Health S.L.
- DenmarkBIMERVAXHipra Human Health S.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99f0a309-04a9-4dfd-bb6c-fb835bc563e7 GET /v1/drugs/99f0a309-04a9-4dfd-bb6c-fb835bc563e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersie voor injectie",
"route": "Intramusculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nuvaxovid-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Covid-19, protein subunit",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132749",
"excipients": [
"CHOLESTEROL",
"DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
"FOSFATIDYLCHOLINE, EI",
"KALIUMCHLORIDE (E 508)",
"NATRIUMCHLORIDE",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 80 (E 433)",
"QUILLAJA SAPONARIA MOLINA SCHORS, GEZUIVERD EXTRACT, FRACTIE A",
"QUILLAJA SAPONARIA MOLINA SCHORS, GEZUIVERD EXTRACT, FRACTIE C",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"RECOMBINANT SPIKE PROTEÏNE ZONDER SIGNAAL PEPTIDE VAN HET SARS-COV-2 VIRUS"
],
"leaflet_url": null,
"authorised_at": "2023/10/31",
"procedure_number": "EMEA/H/C/005808",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/21/1618",
"additional_monitoring": "Y"
}See everything about covid-19, protein-untereinheit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.